Year |
Citation |
Score |
2015 |
Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, ... ... Higgins D, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/Jamaneurol.2015.2736 |
0.666 |
|
2012 |
Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, Tully HM, Bird T, Panegyres PK, Nichter CA, Higgins DS, Helmers SL, Factor SA, Jones R, Testa CM. Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1797-800. PMID 23124580 DOI: 10.1002/Mds.25237 |
0.534 |
|
2008 |
Hutter CM, Samii A, Factor SA, Nutt JG, Higgins DS, Bird TD, Griffith A, Roberts JW, Leis BC, Montimurro JS, Kay DM, Edwards KL, Payami H, Zabetian CP. Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 15: 134-9. PMID 18093156 DOI: 10.1111/J.1468-1331.2007.02012.X |
0.303 |
|
2007 |
Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Kay DM, Yearout D, Montimurro JS, Edwards KL, Samii A, Payami H. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Annals of Neurology. 62: 137-44. PMID 17514749 DOI: 10.1002/Ana.21157 |
0.356 |
|
2004 |
Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G, Roberts SA, Gayán J, Brocklebank D, Cherny SS, Cardon LR, Gray J, Dlouhy SR, ... ... Higgins DS, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proceedings of the National Academy of Sciences of the United States of America. 101: 3498-503. PMID 14993615 DOI: 10.1073/Pnas.0308679101 |
0.586 |
|
2000 |
Talpade DJ, Greene JG, Higgins DS, Greenamyre JT. In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone. Journal of Neurochemistry. 75: 2611-21. PMID 11080215 DOI: 10.1046/J.1471-4159.2000.0752611.X |
0.6 |
|
2000 |
Hoyt KR, McLaughlin BA, Higgins DS, Reynolds IJ. Inhibition of glutamate-induced mitochondrial depolarization by tamoxifen in cultured neurons. The Journal of Pharmacology and Experimental Therapeutics. 293: 480-6. PMID 10773018 |
0.697 |
|
1999 |
Higgins DS, Hoyt KR, Baic C, Vensel J, Sulka M. Metabolic and glutamatergic disturbances in the Huntington's disease transgenic mouse. Annals of the New York Academy of Sciences. 893: 298-300. PMID 10672253 DOI: 10.1111/J.1749-6632.1999.Tb07841.X |
0.646 |
|
1997 |
Kilbourn MR, Charalambous A, Frey KA, Sherman P, Higgins DS, Greenamyre JT. Intrastriatal neurotoxin injections reduce in vitro and in vivo binding of radiolabeled rotenoids to mitochondrial complex I. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 265-72. PMID 9119899 DOI: 10.1097/00004647-199703000-00003 |
0.632 |
|
1996 |
Higgins DS, Greenamyre JT. [3H]dihydrorotenone binding to NADH: ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 3807-16. PMID 8656275 DOI: 10.1523/Jneurosci.16-12-03807.1996 |
0.655 |
|
1995 |
Charalambous A, Tluczek L, Frey KA, Higgins DS, Greenamyre TJ, Kilbourn MR. Synthesis and biological evaluation in mice of (2-[11C]methoxy)-6',7'-dihydrorotenol, a second generation rotenoid for marking mitochondrial complex I activity. Nuclear Medicine and Biology. 22: 491-6. PMID 7550026 DOI: 10.1016/0969-8051(94)00129-8 |
0.323 |
|
1994 |
Albin RL, Howland MM, Higgins DS, Frey KA. Autoradiographic quantification of muscarinic cholinergic synaptic markers in bat, shrew, and rat brain. Neurochemical Research. 19: 581-9. PMID 8065514 DOI: 10.1007/Bf00971334 |
0.368 |
|
1994 |
Porter RH, Greene JG, Higgins DS, Greenamyre JT. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 7192-9. PMID 7965108 DOI: 10.1523/Jneurosci.14-11-07192.1994 |
0.736 |
|
1992 |
Greenamyre JT, Higgins DS, Eller RV. Quantitative autoradiography of dihydrorotenone binding to complex I of the electron transport chain. Journal of Neurochemistry. 59: 746-9. PMID 1629744 |
0.619 |
|
1991 |
Albin RL, Sakurai SY, Makowiec RL, Higgins DS, Young AB, Penney JB. Excitatory amino acid, GABA(A), and GABA(B) binding sites in human striate cortex. Cerebral Cortex (New York, N.Y. : 1991). 1: 499-509. PMID 1668367 DOI: 10.1093/Cercor/1.6.499 |
0.625 |
|
1990 |
Greenamyre JT, Higgins DS, Young AB, Penney JB. Regional ontogeny of a unique glutamate recognition site in rat brain: an autoradiographic study. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 8: 437-45. PMID 2174635 DOI: 10.1016/0736-5748(90)90076-E |
0.717 |
|
1990 |
Greenamyre JT, Higgins DS, Young AB. Sodium-dependent D-aspartate 'binding' is not a measure of presynaptic neuronal uptake sites in an autoradiographic assay. Brain Research. 511: 310-8. PMID 2159361 DOI: 10.1016/0006-8993(90)90176-C |
0.657 |
|
Low-probability matches (unlikely to be authored by this person) |
2011 |
Factor SA, Steenland NK, Higgins DS, Molho ES, Kay DM, Montimurro J, Rosen AR, Zabetian CP, Payami H. Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 564-8. PMID 20884673 DOI: 10.1136/Jnnp.2010.222042 |
0.293 |
|
2011 |
Factor SA, Steenland NK, Higgins DS, Molho ES, Kay DM, Montimurro J, Rosen AR, Zabetian CP, Payami H. Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2190-5. PMID 21714002 DOI: 10.1002/Mds.23806 |
0.292 |
|
2015 |
Mata IF, Jang Y, Kim CH, Hanna DS, Dorschner MO, Samii A, Agarwal P, Roberts JW, Klepitskaya O, Shprecher DR, Chung KA, Factor SA, Espay AJ, Revilla FJ, Higgins DS, et al. The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease. Molecular Neurodegeneration. 10: 50. PMID 26399558 DOI: 10.1186/S13024-015-0045-4 |
0.291 |
|
2009 |
Kay D, Montimurro J, Schlossmacher M, Bresnick E, Stevens C, Zabetian C, Factor S, Higgins D, Scherzer C, Payami H. P3.039 Polymorphisms in the transcription factor gene GATA2 and GATA-2 target region in a-synuclein (SNCA) are associated with Parkinson's disease (PD) Parkinsonism & Related Disorders. 15: S158. DOI: 10.1016/S1353-8020(09)70603-0 |
0.287 |
|
2008 |
McCulloch CC, Kay DM, Factor SA, Samii A, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Montimurro JS, Zabetian CP, Payami H. Exploring gene-environment interactions in Parkinson's disease. Human Genetics. 123: 257-65. PMID 18210157 DOI: 10.1007/S00439-008-0466-Z |
0.284 |
|
2009 |
Hamza T, Factor S, Molho E, Montimurro J, Pratt D, Rosen A, Higgins D, Payami H. P2.110 Evidence for association of high-dose levodopa therapy with intellectual and psychiatric complications of Parkinson's disease Parkinsonism & Related Disorders. 15: S119. DOI: 10.1016/S1353-8020(09)70461-4 |
0.278 |
|
2006 |
Kay DM, Bird TD, Zabetian CP, Factor SA, Samii A, Higgins DS, Nutt J, Roberts JW, Griffith A, Leis BC, Montimurro JS, Philpott S, Payami H. Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease. Genetic Testing. 10: 221-7. PMID 17020475 DOI: 10.1089/Gte.2006.10.221 |
0.274 |
|
2006 |
Elbaz A, Nelson LM, Payami H, Ioannidis JP, Fiske BK, Annesi G, Carmine Belin A, Factor SA, Ferrarese C, Hadjigeorgiou GM, Higgins DS, Kawakami H, Krüger R, Marder KS, Mayeux RP, et al. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. The Lancet. Neurology. 5: 917-23. PMID 17052658 DOI: 10.1016/S1474-4422(06)70579-8 |
0.271 |
|
2007 |
Nichols WC, Marek DK, Pauciulo MW, Pankratz N, Halter CA, Rudolph A, Shults CW, Wojcieszek J, Foroud T, Shults C, Marshall F, Oakes D, Shinaman A, Marder K, Conneally PM, ... ... Higgins D, et al. R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation Movement Disorders. 22: 254-257. PMID 17149721 DOI: 10.1002/Mds.21233 |
0.271 |
|
2006 |
Kay DM, Zabetian CP, Factor SA, Nutt JG, Samii A, Griffith A, Bird TD, Kramer P, Higgins DS, Payami H. Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 519-23. PMID 16250030 DOI: 10.1002/Mds.20751 |
0.27 |
|
2006 |
Higgins DS. Huntington's Disease. Current Treatment Options in Neurology. 8: 236-44. PMID 16569382 DOI: 10.1007/S11940-006-0014-X |
0.268 |
|
2008 |
Kay DM, Factor SA, Samii A, Higgins DS, Griffith A, Roberts JW, Leis BC, Nutt JG, Montimurro JS, Keefe RG, Atkins AJ, Yearout D, Zabetian CP, Payami H. Genetic association between alpha-synuclein and idiopathic Parkinson's disease. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 1222-30. PMID 18404644 DOI: 10.1002/Ajmg.B.30758 |
0.267 |
|
2006 |
Factor SA, Higgins DS, Qian J. Primary progressive freezing gait: a syndrome with many causes. Neurology. 66: 411-4. PMID 16476942 DOI: 10.1212/01.Wnl.0000196469.52995.Ab |
0.266 |
|
2018 |
Wolpaw JR, Bedlack RS, Reda DJ, Ringer RJ, Banks PG, Vaughan TM, Heckman SM, McCane LM, Carmack CS, Winden S, McFarland DJ, Sellers EW, Shi H, Paine T, Higgins DS, et al. Independent home use of a brain-computer interface by people with amyotrophic lateral sclerosis. Neurology. PMID 29950436 DOI: 10.1212/Wnl.0000000000005812 |
0.266 |
|
2010 |
Kay DM, Stevens CF, Hamza TH, Montimurro JS, Zabetian CP, Factor SA, Samii A, Griffith A, Roberts JW, Molho ES, Higgins DS, Gancher S, Moses L, Zareparsi S, Poorkaj P, et al. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2. Neurology. 75: 1189-94. PMID 20876472 DOI: 10.1212/Wnl.0B013E3181F4D832 |
0.263 |
|
2010 |
Mata IF, Shi M, Agarwal P, Chung KA, Edwards KL, Factor SA, Galasko DR, Ginghina C, Griffith A, Higgins DS, Kay DM, Kim H, Leverenz JB, Quinn JF, Roberts JW, et al. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Archives of Neurology. 67: 1350-6. PMID 21060011 DOI: 10.1001/Archneurol.2010.279 |
0.262 |
|
2006 |
Zabetian CP, Hutter CM, Yearout D, Lopez AN, Factor SA, Griffith A, Leis BC, Bird TD, Nutt JG, Higgins DS, Roberts JW, Kay DM, Edwards KL, Samii A, Payami H. LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. American Journal of Human Genetics. 79: 752-8. PMID 16960813 DOI: 10.1086/508025 |
0.26 |
|
2016 |
McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, ... ... Higgins DS, et al. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. PMID 27913695 DOI: 10.1212/Wnl.0000000000003478 |
0.249 |
|
2008 |
Powers KM, Kay DM, Factor SA, Zabetian CP, Higgins DS, Samii A, Nutt JG, Griffith A, Leis B, Roberts JW, Martinez ED, Montimurro JS, Checkoway H, Payami H. Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 88-95. PMID 17987647 DOI: 10.1002/Mds.21782 |
0.244 |
|
2010 |
Seegal RF, Marek KL, Seibyl JP, Jennings DL, Molho ES, Higgins DS, Factor SA, Fitzgerald EF, Hills EA, Korrick SA, Wolff MS, Haase RF, Todd AC, Parsons P, McCaffrey RJ. Occupational exposure to PCBs reduces striatal dopamine transporter densities only in women: a beta-CIT imaging study. Neurobiology of Disease. 38: 219-25. PMID 20096358 DOI: 10.1016/J.Nbd.2010.01.009 |
0.243 |
|
2006 |
Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T, Nichols WC, Shults C, Marshall F, Oakes D, Shinaman A, Marder K, Conneally PM, ... ... Higgins D, et al. Mutations in LRRK2 other than G2019S are rare in a north-American based sample of familial Parkinson's didease Movement Disorders. 21: 2257-2260. PMID 17078063 DOI: 10.1002/Mds.21162 |
0.241 |
|
2007 |
Cardona-Garcia OD, Higgins DS, Molho ES. Botulinum toxin in the management of dystonia. Current Treatment Options in Neurology. 9: 224-33. PMID 17445500 DOI: 10.1007/Bf02938412 |
0.239 |
|
2009 |
Payami H, Kay D, Stevens C, Montimurro J, Hamza T, Zabetian C, Factor S, Higgins D, Moses L, Zareparsi S, Schellenberg G, Nutt J. P2.067 Resolving mode-of-inheritance and association of PRKN with PD in a comprehensive sequence and copy-number-variation (CNV) analysis of 3800 subjects Parkinsonism & Related Disorders. 15: S106-S107. DOI: 10.1016/S1353-8020(09)70418-3 |
0.23 |
|
2001 |
Kieburtz K, Penney JB, Corno P, Ranen N, Shoulson I, Feigin A, Abwender D, Greenarnyre JT, Higgins D, Marshall FJ, Goldstein J, Steinberg K, Shih C, Richard I, Hickey C, et al. Unified huntington’s disease rating scale: Reliability and consistency Neurology. 11: 136-142. PMID 8684382 DOI: 10.1002/Mds.870110204 |
0.222 |
|
2001 |
Higgins DS. Chorea and its disorders. Neurologic Clinics. 19: 707-22, vii. PMID 11532650 DOI: 10.1016/S0733-8619(05)70041-4 |
0.222 |
|
2011 |
Seegal RF, Fitzgerald EF, Hills EA, Wolff MS, Haase RF, Todd AC, Parsons P, Molho ES, Higgins DS, Factor SA, Marek KL, Seibyl JP, Jennings DL, McCaffrey RJ. Estimating the half-lives of PCB congeners in former capacitor workers measured over a 28-year interval. Journal of Exposure Science & Environmental Epidemiology. 21: 234-46. PMID 20216575 DOI: 10.1038/Jes.2010.3 |
0.214 |
|
2013 |
Seegal RF, Fitzgerald EF, McCaffrey RJ, Shrestha S, Hills EA, Wolff MS, Haase RF, Todd AC, Parsons PJ, Molho ES, Higgins DS, Factor SA, Seibyl JP. Tibial bone lead, but not serum polychlorinated biphenyl, concentrations are associated with neurocognitive deficits in former capacitor workers. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 55: 552-62. PMID 23618890 DOI: 10.1097/Jom.0B013E318285F3Fd |
0.204 |
|
2009 |
Molho ES, Agarwal N, Regan K, Higgins DS, Factor SA. Effect of cervical dystonia on employment: A retrospective analysis of the ability of treatment to restore premorbid employment status. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1384-7. PMID 19441129 DOI: 10.1002/Mds.22622 |
0.203 |
|
1986 |
Hassan MN, Reches A, Kuhn C, Higgins D, Fahn S. Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide Clinical Neuropharmacology. 9: 71-78. PMID 3829008 DOI: 10.1097/00002826-198602000-00008 |
0.182 |
|
2018 |
Bravata DM, Myers LJ, Arling G, Miech EJ, Damush T, Sico JJ, Phipps MS, Zillich AJ, Yu Z, Reeves M, Williams LS, Johanning J, Chaturvedi S, Baye F, Ofner S, ... ... Higgins DS, et al. Quality of Care for Veterans With Transient Ischemic Attack and Minor Stroke. Jama Neurology. PMID 29404578 DOI: 10.1001/Jamaneurol.2017.4648 |
0.168 |
|
2005 |
Kay DM, Kramer P, Higgins D, Zabetian CP, Payami H. Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1077-8. PMID 16001413 DOI: 10.1002/Mds.20618 |
0.133 |
|
1986 |
Hassan MN, Higgins D, Traub M, Fahn S. Chronic treatment with bromocriptine induces behavioral supersensitivity in rats Life Sciences. 39: 513-518. PMID 3090394 DOI: 10.1016/0024-3205(86)90507-2 |
0.131 |
|
2005 |
Bennett GA, Withers J, Thomas PW, Higgins DS, Bailey J, Parry L, Davies E. A randomised trial of early warning signs relapse prevention training in the treatment of alcohol dependence. Addictive Behaviors. 30: 1111-24. PMID 15925121 DOI: 10.1016/j.addbeh.2004.10.008 |
0.055 |
|
1996 |
Higgins D, Garcia-Osuna M, Greenamyre J. Neuroleptic effects on the respiratory chain Biological Psychiatry. 39: 553. DOI: 10.1016/0006-3223(96)84132-1 |
0.052 |
|
1987 |
Buss DM, Gomes M, Higgins DS, Lauterbach K. Tactics of manipulation. Journal of Personality and Social Psychology. 52: 1219-29. PMID 3598864 DOI: 10.1037/0022-3514.52.6.1219 |
0.049 |
|
1986 |
Higgins D. The Processes of Reorganizing Local Government in Canada Canadian Journal of Political Science. 19: 219-242. DOI: 10.1017/S0008423900053993 |
0.043 |
|
1979 |
Higgins D. A Guide to Local Government in Nova ScotiaKell Antoft, ed. Halifax: Institute of Public Affairs, Dalhousie University, 1977, pp. xvi, 186 Canadian Journal of Political Science. 12: 646-647. DOI: 10.1017/S0008423900051866 |
0.036 |
|
2022 |
Gao J, Moran E, Higgins DS, Mecher C. Predicting High-risk and High-cost Patients for Proactive Intervention. Medical Care. PMID 35640025 DOI: 10.1097/MLR.0000000000001737 |
0.03 |
|
1977 |
Higgins DS. Policy on computer-related activities Acm Sigcsim Installation Management Review. 6: 5-8. DOI: 10.1145/1125344.1125346 |
0.026 |
|
1999 |
Bennett GA, Higgins DS. Accidental overdose among injecting drug users in Dorset, UK. Addiction (Abingdon, England). 94: 1179-89. PMID 10615733 |
0.021 |
|
1986 |
Higgins DS. Line numbering for IBM DisplayWrite 3 legal documents Acm Sigsmall/Pc Notes. 12: 27-35. DOI: 10.1145/382182.383011 |
0.011 |
|
1986 |
Higgins DS. Screen editor and emulator Acm Sigsmall/Pc Notes. 12: 23-26. DOI: 10.1145/382182.383010 |
0.01 |
|
1985 |
Higgins DS. PC/370 virtual machine Acm Sigsmall/Pc Notes. 11: 23-28. DOI: 10.1145/382167.383025 |
0.01 |
|
1982 |
Higgins DS. Virtual machines on microprocessor hosts Acm Sigsmall Newsletter. 8: 14-16. DOI: 10.1145/1164693.1164697 |
0.01 |
|
1975 |
Higgins DS. A structured FORTRAN translator Acm Sigplan Notices. 10: 42-48. DOI: 10.1145/953438.953444 |
0.01 |
|
Hide low-probability matches. |